Tenet Healthcare (NYSE: THC) director sells 1,300 shares
Rhea-AI Filing Summary
TENET HEALTHCARE CORP (THC) reported that director Cecil D. Haney sold 1,300 shares of common stock on 2026-08-24. The sale was reported as a non-derivative transaction in an open market or private transaction at a price of $278.03 per share, leaving him with 12,553 directly held shares. The Rule 10b5-1 checkbox was left unchecked, and no footnotes were provided.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Seller: 1,300 shares
Net Sell
1 txn
Insider
HANEY CECIL D
Role
Director
Sold
1,300 shs ($361K)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 1,300 | $278.03 | $361K |
Holdings After Transaction:
Common Stock — 12,553 shares (Direct)
Key Figures
Shares sold: 1,300 shares of Common Stock
Sale price per share: $278.03 per share
Shares owned after transaction: 12,553 shares
+1 more
4 metrics
Shares sold
1,300 shares of Common Stock
Non-derivative sale on 2026-08-24 by director Cecil D. Haney
Sale price per share
$278.03 per share
Reported price for 1,300-share sale of THC common stock
Shares owned after transaction
12,553 shares
Directly held by Cecil D. Haney following the reported sale
Transactions reported
1 sale transaction
Form 4 shows one non-derivative sale of common stock
Key Terms
Form 4, non-derivative, Rule 10b5-1, open market or private transaction
4 terms
Form 4 regulatory
"INSIDER FILING DATA (Form 4)"
Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.
non-derivative financial
"the transaction_type was labeled as "non-derivative""
Rule 10b5-1 regulatory
"The filing’s Rule 10b5-1 checkbox is unchecked"
Rule 10b5-1 is a regulation that allows company insiders to buy or sell their shares at predetermined times, even if they have access to non-public information. It acts like setting a schedule in advance for transactions, helping prevent accusations of unfair trading. This rule provides a way for insiders to plan trades transparently, giving investors confidence that these transactions are not based on hidden information.
open market or private transaction financial
"transaction_code_description: "Sale in open market or private transaction""
FAQ
What insider transaction did THC director Cecil D. Haney report?
Cecil D. Haney reported a sale of 1,300 shares of TENET HEALTHCARE CORP common stock on 2026-08-24 in a non-derivative, open market or private transaction at $278.03 per share, leaving him with 12,553 shares held directly.
At what price did Cecil D. Haney sell THC stock?
Cecil D. Haney reported selling 1,300 THC shares at a price of $278.03 per share in a non-derivative transaction on 2026-08-24, described as a sale in an open market or private transaction.
Was the THC insider sale made under a Rule 10b5-1 trading plan?
The filing’s Rule 10b5-1 checkbox is unchecked, indicating the reported 1,300-share sale of THC common stock on 2026-08-24 was not affirmatively stated to be made under a Rule 10b5-1 trading plan.
What type of security did Cecil D. Haney trade in this THC Form 4?
Cecil D. Haney traded Common Stock of TENET HEALTHCARE CORP in a non-derivative transaction, selling 1,300 shares on 2026-08-24 and reporting direct ownership of 12,553 shares afterward.
AI-generated analysis. How Rhea-AI works. Not financial advice.
